Koerber, S A; Höcht, S; Aebersold, Daniel; Albrecht, C; Boehmer, D; Ganswindt, U; Schmidt-Hegemann, N-S; Hölscher, T; Mueller, A-C; Niehoff, P; Peeken, J C; Pinkawa, M; Polat, B; Spohn, S K B; Wolf, F; Zamboglou, C; Zips, D; Wiegel, T (2024). Prostate cancer and elective nodal radiation therapy for cN0 and pN0-a never ending story? : Recommendations from the prostate cancer expert panel of the German Society of Radiation Oncology (DEGRO). Strahlentherapie und Onkologie, 200(3), pp. 181-187. Springer 10.1007/s00066-023-02193-4
|
Text
s00066-023-02193-4.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (264kB) | Preview |
For prostate cancer, the role of elective nodal irradiation (ENI) for cN0 or pN0 patients has been under discussion for years. Considering the recent publications of randomized controlled trials, the prostate cancer expert panel of the German Society of Radiation Oncology (DEGRO) aimed to discuss and summarize the current literature. Modern trials have been recently published for both treatment-naïve patients (POP-RT trial) and patients after surgery (SPPORT trial). Although there are more reliable data to date, we identified several limitations currently complicating the definitions of general recommendations. For patients with cN0 (conventional or PSMA-PET staging) undergoing definitive radiotherapy, only men with high-risk factors for nodal involvement (e.g., cT3a, GS ≥ 8, PSA ≥ 20 ng/ml) seem to benefit from ENI. For biochemical relapse in the postoperative situation (pN0) and no PSMA imaging, ENI may be added to patients with risk factors according to the SPPORT trial (e.g., GS ≥ 8; PSA > 0.7 ng/ml). If PSMA-PET/CT is negative, ENI may be offered for selected men with high-risk factors as an individual treatment approach.
Item Type: |
Journal Article (Review Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology |
UniBE Contributor: |
Aebersold, Daniel Matthias |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1439-099X |
Publisher: |
Springer |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
26 Jan 2024 15:00 |
Last Modified: |
20 Feb 2024 00:16 |
Publisher DOI: |
10.1007/s00066-023-02193-4 |
PubMed ID: |
38273135 |
Uncontrolled Keywords: |
ENI Pelvic irradiation Pelvic nodal treatment Prostate carcinoma Radiotherapy |
BORIS DOI: |
10.48350/192147 |
URI: |
https://boris.unibe.ch/id/eprint/192147 |